SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC - the obesity pill stock
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cuong Huy Nguyen who wrote (78)9/23/1996 12:59:00 PM
From: P.Prazeres   of 113
 
With the continued weakness in this stock, the question that I have is "What would it take to make the holders of this stock to finally sell it?"
IMO the fundamentals have changed. Could you imagine what would happen to the stock if this FDA public debate negatively impacts Redux and how it can be sold and/or used?
What if Knoll's product is approved?
These are some of the scenarios that should be pondered when considering whether to
buy more or to liquidate your position. These points also give more selling pressure from the short side of the market.

Technically, IPIC is failed to hold above its 50 day moving average and is getting close to
the lower support of ~22-1/2.

It wouldn't surprise me to see the tock in the uppper teens IF it falls and closes below 22-1/2.

Just some thoughts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News